HOME >> MEDICINE >> NEWS
Herbal weight-loss product information can be misleading

Many Internet sites marketing and advertising dietary supplements containing the herb ephedra are posting false or misleading information, a Johns Hopkins study demonstrates.

Internists at Johns Hopkins searched the Internet for sites selling herbal weight-loss products including ephedra, then evaluated the information posted on those sites for medical accuracy. Their report appears in a recent issue of Mayo Clinic Proceedings.

Of the 32 Web sites analyzed, 13 (41 percent) failed to disclose potential adverse health effects, and 17 (53 percent) did not reveal the recommended dosage. More importantly, researchers said, 11 sites (34 percent) contained incorrect or misleading statements, some of which could directly result in serious harm to consumers.

In addition, several sites incorrectly compared ephedra to sinus medications, and two sites claimed falsely that ephedra could be used to treat diseases such as asthma or bronchitis, a promotion that is not allowed under the Dietary Supplement Health and Education Act of 1994.

Serious side effects include heart attacks, strokes, arrhythmias, increased blood pressure and heart palpitations, according to lead study author Bimal H. Ashar, M.D., an assistant professor of medicine. It's important that consumers understand the substances are not approved by the U.S. Food and Drug Administration, he says. Most clinical studies examining ephedra for weight loss have documented adverse effects in 20 percent to 60 percent of patients.

"Basically, if it reads like it's too good to be true, it probably is," Ashar says. "If you're really interested in taking any of these supplements based on what you read, first print out the information and take it to your doctor for review."


'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
3-Sep-2003


Page: 1

Related medicine news :

1. Herbal extract as effective as commonly prescribed anti-depressant
2. Herbal, nutritional supplements linked to ocular side effects
3. Herbal supplements testing topic of discussion at chemistry meeting March 30
4. Herbal dietary supplement alters metabolism of chemotherapy drug
5. Herbal assisted weight loss causes neurological ailment in woman
6. Herbal extract is an effective treatment for hay fever
7. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
8. Preliminary Study Proves Centuries Of Herbalists Right About Echinacea
9. UCSF Recruting Breast Cancer Patients For Herbal Therapy Study
10. Similar results found in both older and younger patients undergoing weight-loss surgery
11. Home exercise equipment increased weight-loss success in study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Herbal weight loss product information can misleading

(Date:5/24/2013)... The leading retail brand Short Dresses ... prom dresses . Now that is quite unbelievable, especially in ... brand name since its origin. The retailer has already revealed ... this huge discount offer will be an added bonanza for ... privileged to announce that Short Dresses is to offer different ...
(Date:5/23/2013)... NY (PRWEB) May 24, 2013 Magnatag’s ... employee absentee patterns and reduces vacation conflicts. A Manufacturing ... problem with vacation conflicts; now employees and managers can ... have any problems. Attendance is important to us and ... are exposed. That may seem harsh but it has ...
(Date:5/23/2013)... May 24, 2013 Sublime Beauty® ... Cellulite Whisperer line, with a 35% discount ... Sale" includes two proprietary products, the Cellulite ... . , Purchasers receive a report "Getting Control ... Gel has a wonderful grapefruit scent," says Kathy ...
(Date:5/23/2013)... -- High blood glucose is associated with poor outcomes ... (IIT) to control hyperglycemia is a common practice in ... consistent benefit and even shows harms associated with the ... Physicians, (ACP) Clinical Guidelines Committee in a new evidence-based ... of Medical Quality . , "Clinicians caring for hospitalized ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Whether working ... Operations Forces and law enforcement need an added layer ... Security Enhancer, Night VISER , is an effective ... motion sensing system to increase border and perimeter security. ... VISER have more than tripled over the past three ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013 Halozyme Therapeutics, ... the appointment of David A. Ramsay ... was most recently Vice President, Corporate Development at ... "With his established financial management experience ... by working in our commercial group for the ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2
Cached News: